CIR
PBH icon

Clear Investment Research’s Prestige Consumer Healthcare PBH Stock Holding History

Clear Investment Research’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11
Closed – – 303
2019
Q3 		$0 Hold
11
– – ﹤0.01% 345
2019
Q2 		$0 Hold
11
– – ﹤0.01% 344
2019
Q1 		$0 Hold
11
– – ﹤0.01% 332
2018
Q4 		$0 Hold
11
– – ﹤0.01% 331
2018
Q3 		$0 Buy
+11
New +$416 ﹤0.01% 339

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Clear Investment Research's PBH Position: Q4 2019 in Review

Clear Investment Research sold out of Prestige Consumer Healthcare (PBH) in Q4 2019, closing a stake of 11 shares.

Clear Investment Research first reported a position in PBH in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 234 funds tracked by Wall St. Rank hold PBH as of Q4 2019.

  • Clear Investment Research reported no remaining Prestige Consumer Healthcare position as of Q4 2019 after selling out during the quarter.
  • Clear Investment Research sold 11 Prestige Consumer Healthcare shares in Q4 2019.
  • Clear Investment Research first reported a position in Prestige Consumer Healthcare in Q3 2018 and held it in 5 quarters.
  • Clear Investment Research's Prestige Consumer Healthcare position peaked at $0 in Q3 2019.
  • 234 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2019.

Based on Clear Investment Research's 13F filing for Q4 2019, filed 4 Feb 2020.